During the past decade, Pacific Shores Medical Group conducted 33 clinical trials. In the 10-year time frame, 33 clinical trials started and 30 clinical trials were completed, i.e. on average, 90.9% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 17 clinical trials were completed. i.e. 188.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Pacific Shores Medical Group" #1 sponsor was "Bristol-Myers Squibb" with 10 trials, followed by "NSABP Foundation Inc" with 10 trials sponsored, "Gilead Sciences" with 9 trials sponsored, "Novartis Pharmaceuticals" with 8 trials sponsored and "Spectrum Pharmaceuticals, Inc" with 8 trials sponsored. Other sponsors include 46 different institutions and companies that sponsored additional 40 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Pacific Shores Medical Group" #1 collaborator was "National Cancer Institute (NCI)" with 10 trials as a collaborator, "Genentech, Inc." with 5 trials as a collaborator, "Bayer" with 2 trials as a collaborator, "Ono Pharmaceutical Co. Ltd" with 2 trials as a collaborator and "Academic and Community Cancer Research United" with 1 trials as a collaborator. Other collaborators include 14 different institutions and companies that were collaborators in the rest 24 trials.

According to Clinical.Site data, the most researched conditions in "Pacific Shores Medical Group" are "Breast Cancer" (20 trials), "Prostate Cancer" (7 trials), "Pancreatic Cancer" (6 trials), "Colorectal Cancer" (5 trials) and "Carcinoma, Non-Small-Cell Lung" (4 trials). Many other conditions were trialed in "Pacific Shores Medical Group" in a lesser frequency.

Most popular intervention types in "Pacific Shores Medical Group" are "Drug" (86 trials), "Biological" (11 trials), "Other" (4 trials), "Procedure" (2 trials) and "Genetic" (1 trials). Other intervention types were less common.

The name of intervention was led by "Docetaxel" (7 trials), "Placebo" (6 trials), "Idelalisib" (5 trials), "Nivolumab" (5 trials) and "cyclophosphamide" (5 trials). Other intervention names were less common.

The vast majority of trials in "Pacific Shores Medical Group" are 71 trials for "All" genders, 14 trials for "Female" genders and 8 trials for "Male" genders.

Currently, there are NaN active trials in "Pacific Shores Medical Group". undefined are not yet recruiting, 3 are recruiting, 14 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 57 completed trials in Pacific Shores Medical Group, undefined suspended trials, and 16 terminated clinical trials to date.

Out of the total trials that were conducted in Pacific Shores Medical Group, 12 "Phase 1" clinical trials were conducted, 40 "Phase 2" clinical trials and 43 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".